Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: July 2024

MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Receives PO from European Distributor for 29 Mullen GOs

Posted on July 24, 2024 by MissionIR

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, has received an order for 29 Mullen GOS from one of its newest European distribution partners. The order for the GOs, which are Mullen’s commercial micro-urban-delivery vehicle, came from GAMA, which … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Receives US Patent for Methods of Treating Acute Traumatic Brain Injury with Its Lead Drug Candidate

Posted on July 24, 2024 by MissionIR

Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), today announced the receipt of U.S. Patent No. 12,042,482. The patent covers methods of treating acute traumatic brain injuries … Continue reading →

Posted in Annovis Bio Inc. ANVS | Leave a comment

InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089, a Promising Treatment for Age-Related Macular Degeneration

Posted on July 24, 2024 by MissionIR

Age-related macular degeneration (“AMD”) is a prevalent eye condition that primarily affects older adults, leading to vision loss in the central part of the retina, known as the macula. This disease significantly impacts the quality of life, making it difficult … Continue reading →

Posted in InMed Pharmaceuticals Inc. INM | Leave a comment

SenesTech Inc.’s (NASDAQ: SNES) Evolve(TM) – Offering Sustainable and Humane Solution to NYC’s Rat Problem

Posted on July 24, 2024 by MissionIR

Following New York City’s recent hard stance in the fight against rodents in the city, its leadership has been under backlash, mainly from People for the Ethical Treatment of Animals (“PETA”). The organization blamed the rat problem on the city’s … Continue reading →

Posted in SenesTech Inc. SNES | Leave a comment

MissionIRNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Subsidiary Announces Warranty Coverage for B4 Chassis Cab

Posted on July 23, 2024 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has announced that its subsidiary, Bollinger Motors, released its full warranty coverage on the Bollinger B4 Chassis Cab, the company’s all-new, all-electric Class 4 commercial truck. “We have designed and … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment

Annovis Bio Inc. (NYSE: ANVS) Announces New Executive Team Members

Posted on July 23, 2024 by MissionIR

Annovis Bio (NYSE: ANVS), a pioneering late-stage clinical drug platform company focusing on transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (“AD”) and Parkinson’s Disease (“PD”), is thrilled to welcome four seasoned professionals to its executive team. Maria Maccecchini, … Continue reading →

Posted in Annovis Bio Inc. ANVS | Leave a comment

Clene Inc. (NASDAQ: CLNN) Presents Updates on CNM-Au8(R) at Emerging Growth Conference 73 – Biotech Feature

Posted on July 23, 2024 by MissionIR

Clene (NASDAQ: CLNN), a biopharmaceutical company, is at the forefront of transforming the treatment of neurodegenerative disorders like ALS (amyotrophic lateral sclerosis) and multiple sclerosis (“MS”). In a recent Emerging Growth Conference 73 – Biotech Feature, Clene presented new findings … Continue reading →

Posted in Clene Inc. CLNN | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) to Validate Earlier Semaglutide Studies with Successful GLP-1-H24-2 Study Dosing

Posted on July 22, 2024 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced the dosing completion of its human pilot study #2, GLP-1-H24-2. Lexaria’s patented DehydraTECH(TM) “drug delivery platform technology” increases bioavailability, improving the way active pharmaceutical ingredients (“APIs”) enter … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) Adds Second Annealing Quantum Computer in the U.S. and Unveils New Hybrid Quantum Solver

Posted on July 22, 2024 by MissionIR

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, continues to make strides in the development and deployment of quantum computing technology. The company recently announced two major advancements: the introduction of a new hybrid quantum … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

SuperCom Ltd.’s (NASDAQ: SPCB) Latest $2.9 Million Government EM Contract Shows Continuing Appeal of its Technology

Posted on July 19, 2024 by MissionIR

SuperCom (NASDAQ: SPCB), a global identity technology provider, reported on July 11 that the company has received new orders from European governments valued at $2.9 million, the third set of orders from European clients in the past 90 days, amounting … Continue reading →

Posted in SuperCom Ltd. SPCB | Leave a comment